Capoor Malini R, Nair Deepthi, Khanna Geetika, Krishna S V, Chintamani M S, Aggarwal Pushpa
Department of Microbiology, Vardhman Mahaveer Medical College & Safdarjung Hospital, New Delhi, India.
Braz J Infect Dis. 2008 Jun;12(3):222-5. doi: 10.1590/s1413-86702008000300012.
The current study determined the spectrum of biliary microflora with special emphasis on enteric fever organisms in patients with acute cholangitis with and without cholelithiasis or other biliary diseases. The patients were divided into three groups: Group A consisted of patients with acute cholecystitis with cholelithiasis; Group B consisted of patients with acute cholecystitis with gastrointestinal ailments requiring biliary drainage and group C consisted of patients with gallbladder carcinoma. Gallbladder, bile and gallstones were subjected to complete microbiological and histopathological examination. Antimicrobial susceptibility of the isolates was performed as per CLSI guidelines. Bacteria were recovered from 17 samples (32%) in Group A, 17 (51.4%) in Group B and 1 (1.6%) in Group C. The most common organisms isolated were Escherichia coli (11, 29.7%), Klebsiella pneumoniae (10, 27%), Citrobacter freundii (3, 8.1%), Salmonella enterica serovar Typhi (3, 8.1%), etc. The majority of Enterobacteriaceae isolates were susceptible to piperacillin-tazobactam and meropenem. As regards Salmonella spp., S. Typhi was isolated from 2 (3.8%) patients in Group A and 1 (16%) in Group C. Antimicrobial susceptibility of potential causative organisms, the severity of the cholecystitis, and the local susceptibility pattern must be taken into consideration when prescribing drugs. A protocol regarding the management of such cases should be formulated based on observations of similar studies.
本研究确定了急性胆管炎患者(无论有无胆石症或其他胆道疾病)胆汁微生物群的范围,特别关注伤寒杆菌。患者分为三组:A组由患有胆石症的急性胆囊炎患者组成;B组由患有需要胆道引流的胃肠道疾病的急性胆囊炎患者组成;C组由胆囊癌患者组成。对胆囊、胆汁和胆结石进行了全面的微生物学和组织病理学检查。按照CLSI指南对分离株进行药敏试验。A组17份样本(32%)、B组17份样本(51.4%)和C组1份样本(1.6%)中分离出细菌。分离出的最常见微生物为大肠埃希菌(11株,29.7%)、肺炎克雷伯菌(10株,27%)、弗氏柠檬酸杆菌(3株,8.1%)、伤寒沙门菌(3株,8.1%)等。大多数肠杆菌科分离株对哌拉西林-他唑巴坦和美罗培南敏感。关于沙门菌属,A组2例(3.8%)患者和C组1例(16%)患者分离出伤寒沙门菌。在开药时必须考虑潜在病原体的药敏情况、胆囊炎的严重程度以及局部药敏模式。应根据类似研究的观察结果制定此类病例的管理方案。